Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab.
El-Shanawany
T M
TM
Department of Immunology, University Hospital of Wales, Cardiff, UK. tariq.el-shanawany@cardiffandvale.wales.nhs.uk
Williams
P E
PE
Jolles
S
S
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D017074:Common Variable Immunodeficiency / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D000069283:Rituximab